mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |